Skip to main content
SGSiteGraph

apdm.com

Wearable Biosensors for Research | Clario

Last scanned Jul 30, 2026, 1:00 AM · 8 views

88

Overall score

Great

Summary

Clario is a leading provider of clinical trial endpoint data solutions — spanning cardiac safety, eCOA, medical imaging, respiratory, precision motion, and clinical adjudication — serving pharmaceutical, biotech, and… This website uses WordPress behind Cloudflare CDN. SEO is excellent (90/100) and accessibility is excellent (100/100). Security scores good (75/100) and performance excellent (90/100). Top issue: robots.txt not found.

Clario

Clario is a leading provider of clinical trial endpoint data solutions — spanning cardiac safety, eCOA, medical imaging, respiratory, precision motion, and clinical adjudication — serving pharmaceutical, biotech, and CRO customers across every phase of drug development. Clario integrates endpoint data from devices, sites, and patients, enabling customers to digitally collect, manage, and analyze clinical evidence, with its platform supporting approximately 70% of FDA and EMA novel drug approvals over the past decade. Founded in 1999 as eResearchTechnology (ERT), Clario employs approximately 4,000 people globally. Thermo Fisher Scientific (NYSE: TMO) completed its acquisition of Clario on March 24, 2026, for $8.875 billion in cash plus potential additional earnout payments. Clario now operates as part of Thermo Fisher's Laboratory Products and Biopharma Services segment.

Top issues to fix

6 issues found · 1 high priority

  • Missing Content-Security-Policy header

    Security

    Add a CSP to control which sources can run scripts — the strongest single defense against XSS.

  • Missing X-Content-Type-Options header

    Security

    Add X-Content-Type-Options: nosniff to stop MIME-sniffing attacks.

  • Missing X-Frame-Options header

    Security

    Add X-Frame-Options (or a CSP frame-ancestors rule) to prevent clickjacking via hidden iframes.

  • robots.txt not found

    SEO

    Publish /robots.txt with a Sitemap: directive to guide crawlers.

  • sitemap.xml not found

    SEO

    Publish an XML sitemap and reference it from robots.txt to speed up page discovery.

  • 20 broken links on the page

    SEO

    Fix or remove broken links — they waste crawl budget and erode user trust.

90

SEO

2 issue(s) found

90

Performance

1.04 s

75

Security

HTTPS & header checks

100

Accessibility

0 issue(s) found

Score history

-6 overall since Jul 22, 2026

Overall
88
SEO
90
Security
75
Performance
90
Accessibility
100

Organization

Company details published in this site's own structured data.

Clario

Clario is a leading provider of clinical trial endpoint data solutions — spanning cardiac safety, eCOA, medical imaging, respiratory, precision motion, and clinical adjudication — serving pharmaceutical, biotech, and CRO customers across every phase of drug development. Clario integrates endpoint data from devices, sites, and patients, enabling customers to digitally collect, manage, and analyze clinical evidence, with its platform supporting approximately 70% of FDA and EMA novel drug approvals over the past decade. Founded in 1999 as eResearchTechnology (ERT), Clario employs approximately 4,000 people globally. Thermo Fisher Scientific (NYSE: TMO) completed its acquisition of Clario on March 24, 2026, for $8.875 billion in cash plus potential additional earnout payments. Clario now operates as part of Thermo Fisher's Laboratory Products and Biopharma Services segment.

Founded
Jan 1, 1999

Contact

Email, phone, and address published on this site's own pages.

Meta tags

Title
Wearable Biosensors for Research | Clario
Description
Explore Clario’s Opal®️ V2R precision motion monitoring and actigraphy solution for digital biomarker endpoint measurement in research.
Canonical
https://clario.com/solutions/precision-motion-for-research/
Language
en-US
Charset
UTF-8
Viewport
width=device-width, initial-scale=1, shrink-to-fit=no
Robots meta
index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1
Manifest

OpenGraph & Twitter Card

OpenGraph

og:title
Precision Motion for Research | Clario
og:description
Explore Clario’s Opal®️ V2R precision motion monitoring and actigraphy solution for digital biomarker endpoint measurement in research.
og:type
article
og:url
https://clario.com/solutions/precision-motion-for-research/

Twitter Card

twitter:card
summary_large_image
twitter:title
twitter:description

Technologies

Detected frameworks, languages, and tools.

Hosting & CDN

Hosting provider
CDN provider
Cloudflare
IP address
ASN

DNS records

TypeValue
A
AAAA
MX
TXT
NS
CAA
CNAME
IPv6 supportNo

TLS / SSL certificate

Version
TLS 1.3
Issuer
Entrust Limited
Subject
clario.com
Valid from
Nov 29, 2025
Valid to
Nov 29, 2026
Days until expiry
122
SAN domains
clario.com

Security headers

  • Strict-Transport-SecurityEnabled
  • Content-Security-PolicyMissing
  • X-Frame-OptionsMissing
  • X-Content-Type-OptionsMissing
  • Referrer-PolicyMissing
  • Permissions-PolicyMissing

Compression: gzip · 1 cookie(s) observed

Content & assets

Headings

H1 1 · H2 6 · H3 8

Links

98 internal · 5 external · 20 broken

Images

38 total · 0 missing alt

Scripts / Styles

36 scripts · 0 stylesheets

JS / CSS size

72.5 KB · 38.6 KB

Page size

275 KB

Robots.txt & Sitemap

robots.txt
Not found
Disallow rules
0
sitemap.xml
Not found
URLs in sitemap
0

SEO issues

  • robots.txt not found
  • sitemap.xml not found

Accessibility issues

No accessibility issues detected.

Scan details

Requested URL
https://apdm.com
Final URL
https://clario.com/solutions/precision-motion-for-research/
HTTP status
200
HTTP version
HTTP/2
Response time
1.03 s
HTML size
275 KB
Redirect chain
https://apdm.com → https://clario.com/solutions/precision-motion-for-research/

See something wrong on this report? Request a correction

Frequently asked questions

What technology does apdm.com use?
apdm.com is built with WordPress.
Is apdm.com secure (HTTPS)?
Yes. apdm.com uses TLS 1.3 with a certificate issued by Entrust Limited, valid until Nov 29, 2026.
Who hosts apdm.com?
Hosting provider information for apdm.com is not available yet.
What is apdm.com's SEO score?
apdm.com scored 90/100 for SEO in the latest analysis (excellent).
What is apdm.com's overall website score?
apdm.com has an overall SiteGraph score of 88/100, combining SEO, performance, security, and accessibility.
What company operates apdm.com?
apdm.com is operated by Clario. Clario is a leading provider of clinical trial endpoint data solutions — spanning cardiac safety, eCOA, medical imaging, respiratory, precision motion, and clinical adjudication — serving pharmaceutical, biotech, and CRO customers across every phase of drug development. Clario integrates endpoint data from devices, sites, and patients, enabling customers to digitally collect, manage, and analyze clinical evidence, with its platform supporting approximately 70% of FDA and EMA novel drug approvals over the past decade. Founded in 1999 as eResearchTechnology (ERT), Clario employs approximately 4,000 people globally. Thermo Fisher Scientific (NYSE: TMO) completed its acquisition of Clario on March 24, 2026, for $8.875 billion in cash plus potential additional earnout payments. Clario now operates as part of Thermo Fisher's Laboratory Products and Biopharma Services segment.
Has apdm.com's score changed over time?
apdm.com's overall score has declined by 6 points (from 94 to 88) since Jul 22, 2026.